Hyperglycemia activates FGFR1 via TLR4/c-Src pathway to induce inflammatory cardiomyopathy in diabetes
Protein tyrosine kinases (RTKs) modulate a wide range of pathophysiological events in several non-malignant disorders, including diabetic complications. To find new targets driving the development of diabetic cardiomyopathy (DCM), we profiled an RTKs phosphorylation array in diabetic mouse hearts an...
Main Authors: | Xiong Chen, Jinfu Qian, Shiqi Liang, Jianchang Qian, Wu Luo, Yujuan Shi, Hong Zhu, Xiang Hu, Gaojun Wu, Xiaokun Li, Guang Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383524000169 |
Similar Items
-
FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma
by: Hanna Gött, et al.
Published: (2022-08-01) -
Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer
by: Laura Pacini, et al.
Published: (2021-05-01) -
Biological Significance and Targeting of the FGFR Axis in Cancer
by: Athina-Myrto Chioni, et al.
Published: (2021-11-01) -
Recombinant expression in E. coli of human FGFR2 with its transmembrane and extracellular domains
by: Adam Bajinting, et al.
Published: (2017-06-01) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
by: Wu Luo, et al.
Published: (2022-11-01)